对糖尿病干预成本效益的再认识

Recognition in Cost-effectiveness of Diabetes Interventions

糖尿病及其并发症控制不力,过早进入中、晚期阶段,可以耗费大量的糖尿病医疗资源,故从循证医学角度再认识糖尿病发生、发展与糖尿病医疗干预成本的相关性尤为必要。糖尿病干预成本的效益类型分为节省成本型、高划算成本型、划算成本型、临界划算成本型和不划算成本型。大多数研究建议糖尿病干预措施应该是成本划算型的,同时许多有力证据表明糖尿病干预措施的理想归位是节省成本型或很划算成本型。优化设计节省成本型和很划算成本型干预方案可以有效控制糖尿病流行现状。

The poor control of diabetes and its complications which would bring the patient＇ s condition early into the medium and late stage,may expend a lot of diabetes medical resources. So from the point of evidence-based medicine,to reunderstand the correlation of the incidence and progression of diabetes with the cost of medical intervention is especially necessary. The classification of cost-effectiveness of diabetes interventions includes cost saving type,highly cost-effective type,cost-effective type,marginally cost-effective type,and not cost-effective type. Most studies suggest that intervention methods for diabetes should be costeffective type,while a large amount of compelling evidence demonstrates that the ideal type of diabetes intervention method is cost saving type or highly cost-effective type. Therefore,optimized designing of intervention methods of cost saving type and highly cost-effective type can effectively control the diabetes epidemic situation.